Life Science & Venture Capital

Event Description

Indiana’s life science ecosystem continues to prosper generating national attention. Anchored by industry leaders such as Lilly, Elanco, Zimmer Biomet and Anthem, the State’s vibrant and uniquely collaborative community boasts statistics that rival coastal hubs of activity. Indiana’s healthcare and life sciences sector has benefitted from investments in facilities, equipment, research and talent, to make a substantial impact on the vitality of state. The continuing vitality of this sector depends on innovation from a diversity of research settings – universities, nonprofit research institutes and industry. And the investors and entrepreneurs in the region are up to the challenge of forming early-stage firms with novel products addressing a compelling unmet need and a strong team, value proposition and exit strategy.

Join us on April 6 for a special event featuring Patricia Martin, President and CEO of BioCrossroads and Kent Hawryluk, President and CEO of MBX Biosciences. MBX Biosciences is an Indiana-based, venture-backed clinical stage biopharmaceutical company pioneering Precision Endocrine Peptide (PEP) therapeutics.

Free to Members, $45 for Guests